Yauheni Baranau

1PUBLICATIONS
4CO-AUTHORS
Models of care and place of birth
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Mar 07, 2023
Six-Year Survival Outcomes for Patients with HER2-Positive Early Breast Cancer Treated with CT-P6 or Reference Trastuzumab: Observational Follow-Up Study of a Phase 3 Randomised Controlled Trial.

Justin Stebbing, Yauheni Baranau, Valery Baryash

Pageof 1